Cargando…
Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η
DNA polymerase η (polη) is of significant value for designing new families of anticancer drugs. This protein takes a role in many stages of the cell cycle, including DNA replication, translesion DNA synthesis, and the repairing process of DNA. According to many studies, a high level of expression of...
Autores principales: | Kalhor, Sepideh, Fattahi, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630280/ https://www.ncbi.nlm.nih.gov/pubmed/36323739 http://dx.doi.org/10.1038/s41598-022-22810-z |
Ejemplares similares
-
Design of ionic liquids containing glucose and choline as drug carriers, finding the link between QM and MD studies
por: Kalhor, Sepideh, et al.
Publicado: (2022) -
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
por: Rechkoblit, Olga, et al.
Publicado: (2018) -
Critical amino acids in human DNA polymerases η and κ involved in erroneous incorporation of oxidized nucleotides
por: Katafuchi, Atsushi, et al.
Publicado: (2010) -
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η
por: Rechkoblit, Olga, et al.
Publicado: (2019) -
Structure and Mechanism of Human DNA Polymerase η
por: Biertümpfel, Christian, et al.
Publicado: (2010)